BlackRock, Inc. Reports 6.8% Ownership in Outset Medical, Inc.

BlackRock, Inc. filed a Schedule 13G/A amendment on October 17, 2025, reporting a 6.8% ownership in Outset Medical, Inc. The filing indicates that BlackRock beneficially owns 1,213,547 shares of common stock, with sole voting power over 1,188,631 shares and sole dispositive power over all 1,213,547 shares. The filing also notes that various persons have the right to receive dividends or proceeds from the sale of the common stock, but no single person's interest exceeds 5% of the total outstanding shares. The amendment was signed by Spencer Fleming, Managing Director of BlackRock, Inc.